TY - JOUR
T1 - Perceived racial, socioeconomic and gender discrimination and its impact on contraceptive choice
AU - Kossler, Karla
AU - Kuroki, Lindsay M.
AU - Allsworth, Jenifer E.
AU - Secura, Gina M.
AU - Roehl, Kimberly A.
AU - Peipert, Jeffrey F.
N1 - Funding Information:
This research was supported in part by a Midcareer Investigator Award in Women's Health Research ( K24 HD01298 ), by a Clinical and Translational Science Award ( UL1RR024992 ) and by Grant Number KL2RR024994 from the National Center for Research Resources (NCRR) , a component of the National Institutes of Health (NIH) and NIH Roadmap for Medical Research. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. Information on NCRR is available at http://www.ncrr.nih.gov/ . Information on Re-engineering the Clinical Research Enterprise can be obtained from http://nihroadmap.nih.gov/clinicalresearch/overview-translational.asp .
PY - 2011/9
Y1 - 2011/9
N2 - Background: The study was conducted to determine whether perceived racial, economic and gender discrimination has an impact on contraception use and choice of method. Methods: We analyzed the first 2,500 women aged 14-45 years enrolled in the Contraceptive CHOICE Project, a prospective cohort study aimed to reduce barriers to obtaining long-acting reversible contraception. Items from the "Experiences of Discrimination" (EOD) scale measured experienced race-, gender- and economic-based discrimination. Results: Overall, 57% of women reported a history of discrimination. Thirty-three percent reported gender- or race-based discrimination, and 24% reported discrimination attributed to socioeconomic status (SES). Prior to study enrollment, women reporting discrimination were more likely to report any contraception use (61% vs. 52%, p<.001) but were more likely to use less effective methods (e.g., barrier methods, natural family planning or withdrawal; 41% vs. 32%, p<.001). In adjusted analyses, gender-, race- or SES-based discrimination were associated with increased current use of less effective methods [adjusted risk ratio (aRR) 1.22, 95% confidence interval (CI) 1.06-1.41; aRR 1.25, CI 1.08-1.45; aRR 1.23, CI 1.06-1.43, respectively]. After enrollment, 66% of women with a history of experience of discrimination chose a long-acting reversible contraceptive method (intrauterine device or implantable) and 35% chose a depo-medroxyprogesterone acetate or contraceptive pill, patch or ring. Conclusions: Discrimination negatively impacts a woman's use of contraception. However, after financial and structural barriers to contraceptive use were eliminated, women with EOD overwhelmingly selected effective methods of contraception. Future interventions to improve access and utilization of contraception should focus on eliminating barriers and targeting interventions that encompass race-, gender- and economic-based discrimination.
AB - Background: The study was conducted to determine whether perceived racial, economic and gender discrimination has an impact on contraception use and choice of method. Methods: We analyzed the first 2,500 women aged 14-45 years enrolled in the Contraceptive CHOICE Project, a prospective cohort study aimed to reduce barriers to obtaining long-acting reversible contraception. Items from the "Experiences of Discrimination" (EOD) scale measured experienced race-, gender- and economic-based discrimination. Results: Overall, 57% of women reported a history of discrimination. Thirty-three percent reported gender- or race-based discrimination, and 24% reported discrimination attributed to socioeconomic status (SES). Prior to study enrollment, women reporting discrimination were more likely to report any contraception use (61% vs. 52%, p<.001) but were more likely to use less effective methods (e.g., barrier methods, natural family planning or withdrawal; 41% vs. 32%, p<.001). In adjusted analyses, gender-, race- or SES-based discrimination were associated with increased current use of less effective methods [adjusted risk ratio (aRR) 1.22, 95% confidence interval (CI) 1.06-1.41; aRR 1.25, CI 1.08-1.45; aRR 1.23, CI 1.06-1.43, respectively]. After enrollment, 66% of women with a history of experience of discrimination chose a long-acting reversible contraceptive method (intrauterine device or implantable) and 35% chose a depo-medroxyprogesterone acetate or contraceptive pill, patch or ring. Conclusions: Discrimination negatively impacts a woman's use of contraception. However, after financial and structural barriers to contraceptive use were eliminated, women with EOD overwhelmingly selected effective methods of contraception. Future interventions to improve access and utilization of contraception should focus on eliminating barriers and targeting interventions that encompass race-, gender- and economic-based discrimination.
KW - Contraception
KW - Discrimination
KW - Gender
KW - Race
KW - Socioeconomic status
UR - http://www.scopus.com/inward/record.url?scp=80051880551&partnerID=8YFLogxK
U2 - 10.1016/j.contraception.2011.01.004
DO - 10.1016/j.contraception.2011.01.004
M3 - Article
C2 - 21843693
AN - SCOPUS:80051880551
SN - 0010-7824
VL - 84
SP - 273
EP - 279
JO - Contraception
JF - Contraception
IS - 3
ER -